Published: 6 January 2021
Author(s): Jesús Ribas, Esther Alba, Yuliana Pascual-González, Yolanda Ruíz, Adriana Iriarte, José María Mora-Luján, Joana Valcárcel, Xavier Corbella, Salud Santos, Elena Escalante, Antoni Riera-Mestre
Issue: May 2021
Section: Original article

Inferior vena cava (IVC) filters are implantable devices created to trap thrombi from the lower extremities and prevent clinically significant pulmonary embolism (PE). According to guidelines, the most widely accepted indication for insertion of an IVC filter is the prevention of PE in a patient with acute venous thromboembolism (VTE) and an absolute contraindication to anticoagulation [1-4]. Other potential indications such as acute PE in patients with poor cardiopulmonary reserve and high-risk PE treated with thrombolysis or thrombectomy are controversial [1,2].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.